We did it, DIN EN ISO 15189 accreditation
We are proud to announce that after extensive preparatory work, our lab has received the accreditation certificate according to DIN EN ISO 15189. Now, we are listed by Deutsche Akkreditierungsstelle (DAkkS) – the national accreditation body of Germany as an accredited medical laboratory.
The rigorous accreditation process involved assessments by two technical and two system assessors, all with extensive experience. Their critical yet fair evaluations concluded with a positive recognition of our laboratory’s dedication and professionalism, particularly in the field of HLA typing.
What purpose does the ISO accreditation serve?
DIN EN ISO 15189 accreditation holds paramount significance as international standards, such as those set by the World Marrow Donor Association (WMDA), which regulate typing services performed by accredited laboratories. Previously showcasing our competence through European Federation for Immunogenetics (EFI) accreditation, this additional accreditation is the first step offering an extended range of diagnostic testing.
What does it mean for the future?
In practical terms, accreditation is a door opener for us to the diagnostics market, participation in clinical trials, and research in the pharmaceutical sector. Here, we want to continue to support and expand our competencies as outlined in the DKMS mission.
What's next?
Looking ahead, we see that accreditation is not a conclusion but a continuation. Regular adjustments to norms ensure the maintenance of the highest standards. Therefore, systematic re-accreditation will be an ongoing commitment, serving as a testament to the sustained quality of our services.
This accreditation marks a significant stride for our lab, positioning us at the forefront of medical excellence and reinforcing our dedication to advancing healthcare and research for blood cancer patients.
